Device Trial Radar · NCT05120193
Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System
Last checked: Nov 20, 2026Latest source record: Apr 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
477
Actual
Start
Dec 14, 2021
Primary completion
Jan 10, 2024
Study completion Jan 10, 2024
Sponsor
- Lead sponsor
- Medtronic Cardiac Ablation SolutionsPublic (MDT)
- Sponsor type
- Industry
- First posted
- Nov 15, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multicenter, randomized clinical evaluation of the Sphere-9 Mapping and Ablation Catheter with the Affera Mapping and Ablation System. Subjects will be randomly assigned 1:1 to receive treatment with either the Sphere-9 Mapping and Ablation Catheter and the Affera Mapping and Ablation System (investigational device) or the THERMOCOOL SMARTTOUCH® SF radiofrequency ablation catheter (control device).
Conditions
- Atrial Fibrillation
Interventions
Mapping and AblationDevice
Minimally invasive catheter mapping and ablation procedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of Subjects With a Primary Adverse EventTime frame: 180 Days
- Percent of Subjects Free From Primary Effectiveness FailureTime frame: 12 months
Locations
23 sites in 3 countries. Site status is shown where the registry gives one.
Arrhythmia Institute at Grandview
Birmingham, Alabama
Banner University Medical Center Phoenix
Phoenix, Arizona
Arrhythmia Research Group
Jonesboro, Arkansas
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.